Ainos, Inc. (NASDAQ:AIMD) Short Interest Up 58.1% in December

Ainos, Inc. (NASDAQ:AIMD) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 255,800 shares, a growth of 58.1% from the November 30th total of 161,800 shares. Based on an average trading volume of 374,300 shares, the short-interest ratio is currently 0.7 days. Currently, 6.1% of the shares of the company are sold short.

Ainos Price Performance

AIMD stock opened at $0.45 on Friday. The stock’s fifty day moving average is $0.47 and its two-hundred day moving average is $0.59. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 0.50. Ainos has a 1 year low of $0.40 and a 1 year high of $4.29.

Ainos (NASDAQ:AIMD) last posted its earnings results on Wednesday, November 6th. The company reported ($0.33) EPS for the quarter. Ainos had a negative return on equity of 75.16% and a negative net margin of 15,348.14%.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.